Hepatology & Liver Transplantation Trials
- Organ Care System (OCS™) Liver ‘REVIVE’ Trial
- UK PBC genetics study
- UK PSC genetics study
- HCV Research UK
- UK-AIH (United Kingdom Autoimmune Hepatitis Cohort)
- AbbVie – A single arm, open label, multicentre study to evaluate the safety and efficacy of ABT-493/ABT-530 in adult post liver or post renal transplant recipients with chronic hepatitis c virus genotype 1-6 (MAGELLAN-2)
- ALLHEAL
- EON
- MAPLE
- Steroid HCC
- ASEPTIC
- NUT-3
- An Open-Label, Multicenter Study to EvaluateLong-Term Outcomes With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I)
- STOP-HCV cirrhosis study
- LIFT Liver Immunosuppression-free trial
- Nucleos(t)ide withdrawal in hepatitis B virus infection (NUC-B)
- CALIBRE
- CHELATE
- WAFT-C Warfarin Anticoagulation for liver fibrosis in patients transplanted for HCV
- LEAN Liraglutides Action and efficacy in NASH
- ELUCIDATE ELF to Uncover Cirrhosis as an indication for Diagnosis and action for treatable events
- ELUCIDATE patients experience
- GILEAD A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects with Genotype 2 or 3 Chronic HCV Infection
- ATTAIN(Retreatment of null and partial responders with TMC435) A Phase III, randomized, double-blind trial to evaluate the efficacy, safety and tolerability of TMC435 vs. telaprevir, both in combination with PegIFNα-2a and ribavirin, in chronic hepatitis C genotype-1 infected subjects who were null or partial responders to prior PegIFNα and ribavirin therapy
- DILIGEN Pharmacogenetics of drug induced liver injury
- STOPAH. Steriods or Pentoxifylline for Alcoholic Hepatitis
- Drug Utilization of DAAs and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Patients
- Hepatitis C Rimantadine and Antiviral Combination Therapy – “HepRiACT” trial
- UK-PBC Nested Cohort Study
- Albumin to prevent infection in chronic liver failure (ATTIRE)
- Phase 2 EDP-305 in patients with primary biliary cholangitis
- AURORA
- ISAIAH
- PROSPER (Prospective Real World Outcomes Study of Hepatic Encephalopathy Patients’ Experience of Rifaximin)
- A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults with Thrombocytopenia Associated with Liver Disease Prior to an Elective Procedure
- GILEAD – A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination in Subjects with Chronic HCV Infection who have received a Liver Transplant
- TACE-2 Research trial evaluating sorafenib in combination with chemoembolization in patients with unresectable advanced Hepatocellular Carcinoma